Literature DB >> 9602360

Amino acid insertions and deletions contribute to diversify the human Ig repertoire.

P Wilson1, Y J Liu, J Banchereau, J D Capra, V Pascual.   

Abstract

The sequence analysis of Ig variable region genes transcribed within different B-cell subpopulations from human tonsil led us to identify a rare DNA sequence modification event consisting of bp insertions and/or deletions (I/D). Although these events were previously reported, they had never been formally associated with the somatic hypermutation process. I/D events share with more conventional somatic hypermutation events their localization within hypervariable regions and, most particularly, within DNA motifs known to be mutational hot spots. Repetitive DNA tracts or DNA elements capable of forming DNA loop intermediates seem to be the preferred substrate for I/D to occur. These characteristics suggest a model for somatic hypermutation reminiscent of the "polymerase slippage" model involved in replication and repair mutations in prokaryotes, yeast, and mammals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9602360     DOI: 10.1111/j.1600-065x.1998.tb01437.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  18 in total

1.  Sequence similarities of protein kinase peptide substrates and inhibitors: comparison of their primary structures with immunoglobulin repeats.

Authors:  J Kubrycht; J Borecký; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

2.  Diversification of the Ig variable region gene repertoire of synovial B lymphocytes by nucleotide insertion and deletion.

Authors:  Yasushi Miura; Charles C Chu; David M Dines; Stanley E Asnis; Richard A Furie; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

3.  Sequence similarities of protein kinase substrates and inhibitors with immunoglobulins and model immunoglobulin homologue: cell adhesion molecule from the living fossil sponge Geodia cydonium. Mapping of coherent database similarities and implications for evolution of CDR1 and hypermutation.

Authors:  J Kubrycht; J Borecký; P Soucek; P Jezek
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

4.  Virginia Pascual, MD: a conversation with the editor.

Authors:  Virginia Pascual; William Clifford Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-01

5.  Immunogenetic factors driving formation of ultralong VH CDR3 in Bos taurus antibodies.

Authors:  Thaddeus C Deiss; Melissa Vadnais; Feng Wang; Patricia L Chen; Ali Torkamani; Waithaka Mwangi; Marie-Paule Lefranc; Michael F Criscitiello; Vaughn V Smider
Journal:  Cell Mol Immunol       Date:  2017-12-04       Impact factor: 11.530

6.  Somatic hypermutation and diverse immunoglobulin gene usage in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae Type 6B.

Authors:  Jianhui Zhou; Kathleen R Lottenbach; Stephen J Barenkamp; Donald C Reason
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

7.  Location and length distribution of somatic hypermutation-associated DNA insertions and deletions reveals regions of antibody structural plasticity.

Authors:  B S Briney; J R Willis; J E Crowe
Journal:  Genes Immun       Date:  2012-06-21       Impact factor: 2.676

8.  Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes.

Authors:  Bryan S Briney; Jordan R Willis; James E Crowe
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

9.  Codon insertion and deletion functions as a somatic diversification mechanism in human antibody repertoires.

Authors:  Donald C Reason; Jianhui Zhou
Journal:  Biol Direct       Date:  2006-08-30       Impact factor: 4.540

10.  Secondary mechanisms of diversification in the human antibody repertoire.

Authors:  Bryan S Briney; James E Crowe
Journal:  Front Immunol       Date:  2013-03-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.